Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate

Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate

Abstract Introduction The objective of this analysis was to assess disease activity metrics using a variety of disease outcome measures following methotrexate (MTX) withdrawal in ORAL Shift, a phase 3b/4 study of tofacitinib with/without MTX, in patients with rheumatoid arthritis (RA) achieving Clin...

Full description

Bibliographic Details
Main Authors: Roy Fleischmann, Boulos Haraoui, Maya H. Buch, David Gold, Gosford Sawyerr, Harry Shi, Annette Diehl, Kristen Lee
Format: Article
Language:English
Published: Adis, Springer Healthcare 2022-12-01
Series:Rheumatology and Therapy
Subjects:
Rheumatoid arthritis
Inflammation
Methotrexate
Therapeutics
Online Access:https://doi.org/10.1007/s40744-022-00511-3

Internet

https://doi.org/10.1007/s40744-022-00511-3

Similar Items